GF Fund Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.1K Hold
1,251
﹤0.01% 477
2025
Q1
$24.6K Buy
1,251
+225
+22% +$4.43K ﹤0.01% 479
2024
Q4
$23.1K Buy
+1,026
New +$23.1K ﹤0.01% 460